Waters Corp (WAT) Stock Price, Quote & News

Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 508 478 2000

Fax: 508 872 1990

Website: www.waters.com

Address:

34 Maple Street, Milford, United States

Stocktwits52wHighs Aug. 12 at 3:31 PM

$WAT printed a new 52-week high today

0 · Reply

ShangVXO Aug. 11 at 3:51 PM

$WAT Dude, I could see this surprising people

0 · Reply

TalkMarkets Aug. 11 at 6:43 AM

BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481

0 · Reply

IN0V8 Aug. 10 at 6:44 PM

$WAT Opportunity Citigroup raises target price to $470 from $425

0 · Reply

CarolDonaldson311 Aug. 5 at 6:46 AM

$WAT $ROP $FMX $ADM $HIG Waters leads analytical instruments, Roper Technologies expands software solutions, FEMSA strengthens consumer businesses, ADM benefits from global agricultural demand, and Hartford Financial delivers stable insurance earnings.

0 · Reply

EarningsInsider Aug. 4 at 1:17 PM

https://www.marketbeat.com/earnings/reports/2026-8-4-waters-co-stock/ $WAT Waters Earnings Transcript

0 · Reply

StocktwitsEarnings Aug. 4 at 10:19 AM

$WAT Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.39 down -156.28% YoY • Reported revenue of $1.65B up 113.27% YoY • Waters Corporation raised its full-year 2026 adjusted EPS guidance to $14.45 to $14.65, representing 10-12% growth, while expecting total reported revenue for the full year of $6.415 billion to $6.476 billion.

0 · Reply

prismmarketview Jul. 20 at 6:57 PM

Women's oncology is entering a new growth phase. A new PwC report projects the market could approach $110 billion by 2030, with investment increasingly expanding beyond breast cancer into ovarian, cervical and endometrial cancers. Our latest examines the trends driving the sector and highlights public companies advancing innovation across earlier detection, targeted therapies and immuno-oncology. $WAT $CORT $VSTM $IMNN $BLRX https://prismmarketview.com/womens-oncology-is-entering-its-next-growth-phase-as-investment-moves-beyond-breast-cancer/

0 · Reply

UpgradeDowngrade Jul. 10 at 2:26 PM

$WAT RBC Capital Mkts has altered their rating of "Outperform" and target of "$435" see consensus outlook

0 · Reply

UpgradeDowngrade Jun. 30 at 2:29 AM

$WAT Bernstein has altered their rating of "Outperform" and target of "$435" see consensus outlook

0 · Reply

Waters Earnings Call Transcript: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 13 days ago

Waters Earnings release: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 13 days ago

Waters Slides: Q2 2026

Aug 4, 2026, 8:00 AM EDT - 13 days ago

Waters Quarterly report: Q2 2026

Aug 4, 2026, 6:00 AM EDT - 13 days ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results

Jul 27, 2026, 8:10 AM EDT - 21 days ago

Waters Launches Industry's Most Sensitive and Robust Clinical IVD System with Xevo TQ Absolute XR IVD Mass Spectrometer

Jul 2, 2026, 6:00 AM EDT - 6 weeks ago

Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call

Jun 24, 2026, 8:00 AM EDT - 7 weeks ago

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Jun 9, 2026, 8:00 AM EDT - 2 months ago

Waters Launches Coin Cell Differential Scanning Calorimeter (DSC) to Advance Battery Safety with Integrated Thermal, Evolved Gas, and Electrochemical Analysis

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Waters Launches Industry-First Reversed-Phase Bioseparation Columns to Deliver Up to 3x Faster GLP-1 Characterization and 2x Faster LNP Component Analysis

Jun 3, 2026, 10:30 AM EDT - 2 months ago

Waters Transcript: Jefferies Global Healthcare Conference 2026

Jun 3, 2026, 8:00 AM EDT - 2 months ago

Waters Announces FDA 510(k) Clearance of BD BACTEC FXI Culture System, Enabling Broader Access to Bloodstream Infection Diagnostics

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Jun 1, 2026, 8:00 AM EDT - 2 months ago

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

May 18, 2026, 4:00 PM EDT - 3 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference

May 5, 2026, 6:47 PM EDT - 3 months ago

Waters CEO highlights China as key innovation source in the biopharma market

May 5, 2026, 10:38 AM EDT - 3 months ago

Waters raises annual profit forecast as biosciences unit drives growth

May 5, 2026, 8:30 AM EDT - 3 months ago

Waters Earnings Call Transcript: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Waters Slides: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Waters Earnings release: Q1 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Waters Quarterly report: Q1 2026

May 5, 2026, 6:00 AM EDT - 3 months ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2026 Financial Results

Apr 20, 2026, 4:15 PM EDT - 4 months ago

Waters Corporation Schedules First Quarter 2026 Earnings Conference Call

Apr 14, 2026, 8:00 AM EDT - 4 months ago

Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Waters Proxy statement: Proxy filing

Apr 9, 2026, 8:00 AM EDT - 4 months ago

Waters Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay

Mar 18, 2026, 6:00 AM EDT - 5 months ago

Waters Prices Offering of Senior Notes

Mar 9, 2026, 8:00 AM EDT - 5 months ago

Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed

Mar 2, 2026, 11:10 AM EST - 6 months ago

Waters Transcript: TD Cowen 46th Annual Health Care Conference

Feb 23, 2026, 4:45 PM EST - 6 months ago

Waters Corporation to Present at the TD Cowen Health Care Conference

Feb 17, 2026, 8:00 AM EST - 6 months ago

Waters Introduces Next-Generation Microflow LC Columns with MaxPeak Premier Technology, Delivering Higher Sensitivity with Lower Sample and Solvent Usage

Feb 9, 2026, 8:40 AM EST - 6 months ago

BD Completes Combination of Biosciences & Diagnostic Solutions Business with Waters Corporation

BDX

Feb 9, 2026, 8:40 AM EST - 6 months ago

Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses

BDX

Feb 9, 2026, 8:30 AM EST - 6 months ago

Waters Earnings Call Transcript: Q4 2025

Feb 9, 2026, 8:30 AM EST - 6 months ago

Waters Annual report: Q4 2025

Feb 9, 2026, 8:30 AM EST - 6 months ago

Waters Earnings release: Q4 2025

Feb 9, 2026, 8:30 AM EST - 6 months ago

Waters Slides: Q4 2025

Feb 9, 2026, 6:30 AM EST - 6 months ago

Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2025 Financial Results

Jan 27, 2026, 9:25 AM EST - 7 months ago

BD Announces Record Date for the Spin-Off of its Biosciences & Diagnostic Solutions Business

BDX

Jan 27, 2026, 9:25 AM EST - 7 months ago

Waters Shareholders Approve Combination with BD's Biosciences & Diagnostic Solutions Business

BDX

Jan 20, 2026, 1:00 PM EST - 7 months ago

Waters Corporation Schedules Fourth Quarter 2025 Earnings Conference Call

Jan 12, 2026, 5:15 PM EST - 7 months ago

Waters Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 5:15 PM EST - 7 months ago

Waters Slides: 44th Annual J.P. Morgan Healthcare Conference

Dec 23, 2025, 11:00 AM EST - 8 months ago

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

Nov 18, 2025, 9:30 AM EST - 9 months ago

Waters Transcript: Jefferies London Healthcare Conference 2025

Nov 11, 2025, 2:00 PM EST - 9 months ago

Waters Corporation to Present at the Jefferies Global Healthcare Conference in London

Nov 11, 2025, 8:00 AM EST - 9 months ago

Waters Boosts Lab Productivity and Sample Throughput with Launch of its Charged Aerosol Detector Designed for Empower Software

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Waters Slides: Q3 2025

Nov 4, 2025, 7:10 AM EST - 10 months ago

Waters Corp raises annual profit forecast on stronger lab equipment demand

Nov 4, 2025, 6:00 AM EST - 10 months ago

Waters Corporation (NYSE: WAT) Reports Third Quarter 2025 Financial Results

Oct 13, 2025, 8:05 AM EDT - 11 months ago

Waters Launches Charge Detection Mass Spectrometry Technology to Accelerate the Development of Next-Generation Biotherapeutics

Oct 1, 2025, 12:00 PM EDT - 11 months ago

Waters Corporation Schedules Third Quarter 2025 Earnings Conference Call

Sep 4, 2025, 9:30 AM EDT - 1 year ago

Waters Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 26, 2025, 4:10 PM EDT - 1 year ago

Waters Corporation to Present at the Wells Fargo Healthcare Conference

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q2 2025

Aug 4, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q2 2025

Aug 4, 2025, 6:00 AM EDT - 1 year ago

Waters Corporation (NYSE: WAT) Reports Second Quarter 2025 Financial Results

Jul 16, 2025, 11:33 AM EDT - 1 year ago

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

BDX

Jul 14, 2025, 1:05 PM EDT - 1 year ago

Top Stock Movers Now: Autodesk, Fortinet, Waters, and More

ADSK FTNT

Jul 14, 2025, 11:20 AM EDT - 1 year ago

Analytics Equipment Maker Waters Buys Becton Dickinson Unit in a $17.5B Deal

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Transcript: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Press release: M&A Announcement

Jul 14, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: M&A Announcement

Jul 14, 2025, 6:15 AM EDT - 1 year ago

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

BDX

Jul 11, 2025, 4:15 PM EDT - 1 year ago

Waters Corporation Schedules Second Quarter 2025 Earnings Conference Call

Jun 17, 2025, 10:00 AM EDT - 1 year ago

Waters Enhances Alliance iS HPLC System Software, Setting a New Standard for End-to-End Traceability and Data Integrity

Jun 4, 2025, 8:45 AM EDT - 1 year ago

Waters Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 8:00 AM EDT - 1 year ago

Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer

May 28, 2025, 8:00 AM EDT - 1 year ago

Waters Introduces BioResolve Protein A Affinity Columns to Accelerate Antibody Titer Measurement, Enhancing Process Agility and Batch Quality

May 21, 2025, 8:00 AM EDT - 1 year ago

Waters Acquires Halo Labs, Expanding Biological Analysis Portfolio

May 15, 2025, 7:48 AM EDT - 1 year ago

Waters Corp's India business boosted by rush for weight-loss drugs

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Quarterly report: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Earnings release: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Waters Slides: Q1 2025

May 6, 2025, 7:21 AM EDT - 1 year ago

Waters raises 2025 profit forecast on resilient demand for lab equipment

May 6, 2025, 6:15 AM EDT - 1 year ago

Waters Integrates Multi-Angle Light Scattering Detectors with Empower Software for Improved Biologics Quality Control and Simplified Regulatory Compliance

May 6, 2025, 6:00 AM EDT - 1 year ago

Waters Corporation (NYSE: WAT) Reports First Quarter 2025 Financial Results

Stocktwits52wHighs Aug. 12 at 3:31 PM

$WAT printed a new 52-week high today

0 · Reply

ShangVXO Aug. 11 at 3:51 PM

$WAT Dude, I could see this surprising people

0 · Reply

TalkMarkets Aug. 11 at 6:43 AM

BDX: A Dividend King In The Medical Supply Business $BDX Also Mentions: $WAT https://talkmarkets.com/article/bdx-a-dividend-king-in-the-medical-supply-business-1786430481

0 · Reply

IN0V8 Aug. 10 at 6:44 PM

$WAT Opportunity Citigroup raises target price to $470 from $425

0 · Reply

CarolDonaldson311 Aug. 5 at 6:46 AM

0 · Reply

EarningsInsider Aug. 4 at 1:17 PM

https://www.marketbeat.com/earnings/reports/2026-8-4-waters-co-stock/ $WAT Waters Earnings Transcript

0 · Reply

StocktwitsEarnings Aug. 4 at 10:19 AM

0 · Reply

prismmarketview Jul. 20 at 6:57 PM

0 · Reply

UpgradeDowngrade Jul. 10 at 2:26 PM

$WAT RBC Capital Mkts has altered their rating of "Outperform" and target of "$435" see consensus outlook

0 · Reply

UpgradeDowngrade Jun. 30 at 2:29 AM

$WAT Bernstein has altered their rating of "Outperform" and target of "$435" see consensus outlook

0 · Reply

BillionerOfKing Jun. 23 at 3:26 PM

$WAT Current Stock Price: $357.98 Contracts to trade: $360.0 WAT Jul 17 2026 Call Entry: $11.90 Exit: $20.68 ROI: 74% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

SuperGreenToday Jun. 22 at 6:15 PM

$WAT Share Price: $357.77 Contract Selected: Jan 15, 2027 $360 Calls Buy Zone: $31.62 – $39.06 Target Zone: $56.95 – $69.60 Potential Upside: 70% ROI Time to Expiration: 206 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

BreakoutsHappen Jun. 5 at 4:51 AM

Watchlist Today $ILMN $CZR $LSTR $WAT https://breakoutshappen.com/scanners/vcp-scanner

0 · Reply

JFDI Jun. 3 at 4:58 PM

$WAT big ol base

0 · Reply

YouOnlyLiveTwice Jun. 1 at 6:44 PM

$WAT These medical device stocks have 2 to 3 Green Day’s per month

0 · Reply

flychicken1991 Jun. 1 at 12:06 PM

news impact: Waters unveiled the Cyclic IMS P20 MS platform for structural and spatial omics, putting instrument adoption and lab workflow upgrades in focus. NewsImpact map: https://clawpool.hihired.org/newsimpact/?ticker=WAT&utm_source=stocktwits&utm_medium=parent_url Watch launch timing, customer uptake, omics workflow demand, margin mix, and life-science tools peer reaction. Not financial advice.$WAT

0 · Reply

Skusek May. 31 at 11:21 PM

$WAT Target 400-450$

0 · Reply

Doozio May. 30 at 4:59 PM

Chop chop huckleberries. Know $WAT ? It was always ONTO 🐒🍌🧠⏰♾️ because he gave da sign n is wUtchin.

0 · Reply

BillionerOfKing May. 26 at 4:14 AM

$WAT Current Stock Price: $342.38 Contracts to trade: $340.0 WAT Jun 18 2026 Call Entry: $11.10 Exit: $19.89 ROI: 79% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CapitalMonk May. 25 at 5:56 PM

$WAT Price: $342.37 (+0.40%) Trend: Bearish Market Bias (7D): Sideways ⚖️ Expected Range: ±1.75% RSI: 70.0 | Momentum: Strong Momentum Volume: -59.3% vs avg Volatility: 3.82% Support: $287.19 | Resistance: $357.45 Sourch: http://marketbaubles.com/

0 · Reply

CapitalMonk May. 21 at 6:15 PM

$WAT Price: $341.32 (-0.00%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±1.11% RSI: 66.3 | Momentum: Strong Momentum Volume: -82.2% vs avg Volatility: 3.83% Support: $287.19 | Resistance: $357.45 Sourch: http://marketbaubles.com/

0 · Reply

Quant73 May. 12 at 4:14 PM

$ISRG Great breakdown of whats happening with $IHI stocks on Griffonomics. $WAT $DHR $SYK Very Bullish for $ISRG https://www.youtube.com/watch?v=7jv0vDOmlV8

0 · Reply

Market Cap	40.49B
Revenue (ttm)	3.17B
Net Income (ttm)	642.63M
EPS (ttm)	N/A
PE Ratio	30.23
Forward PE	28.38
Profit Margin	20.30%
Debt to Equity Ratio	0.00

Volume	608,769
Avg Vol	890,804
Day's Range	N/A - N/A
Shares Out	98.25M
Stochastic %K	80%
Beta	1.19
Analysts	Strong Sell
Price Target	$437.74